ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2024
Data-Driven Evidence-Based Patient-Centered Optimal Initiation Time for Dialysis Treatment.
Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we propose a novel decision-making framework based on natural-language processing, machine learning and stochastic modeling for the purpose of providing a data-driven perspective to optimize the initiation time for dialysis treatment. When to start dialysis treatment is an important decision for end-stage chronic kidney disease (CKD) care. In the absence of a national guideline, determining the best time to start dialysis remains a challenge. Our decision support framework for optimizing the initiation time includes (a) a comprehensive, efficient "pipeline" for extracting, de-identifying, and standardizing EHR data; (b) an informatics toolkit that couples natural language processing and event mapping, clustering and machine learning to uncover the disease prognosis and treatment effects, and deduce the symptoms and utility rewards for each disease-action stage; (c) a first-of-its-kind, personalized, dialysis-timing stochastic model to determine the optimal initiation time; and (d) a clinical practice guideline (CPG) for systematic testing and implementation in the clinical setting. We evaluate the results using utility rewards for each decision process and published financial costs for each CKD disease and treatment stage. Compared to current clinical policy, the optimal initiation-time policies offer a potential 20.0% to 54.7% mortality reduction, an increase of 6.4% to 14.7% in overall utility reward and a reduction of 9.6% to 16.7% in overall cost. Working with nephrologists and a CKD/ESRD care team, a CPG was developed and tested in the clinic. Initial usage shows promising results. Follow-on clinical trials will gauge the overall effectiveness and impact on patient care of our approach. The new CPG has the potential to become a national standard.
Indexed as
Identifiers
41726465PMC12919589What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.